NewsCase StudiesEvents

GlaxoSmithKline investing in Greece

Also in the news...

Hundreds of Scottish businesses set to benefit as UK launches trade deal with Gulf nations

The landmark deal is expected to add at least £270 million a year to the Scottish economy, with food and drink and renewable energy businesses set to benefit.

Multi-year UAE business licenses highly discounted

Running throughout the summer, Charterhouse Lombard is offering cost-effective setup packages with the option of buying a multi-year license at a significant discount. Get in touch with us today to ask about:

Joint Statement on UK-Thailand Joint Economic and Trade Committee

A Joint Statement between the United Kingdom and Thailand concluding the first Joint Economic and Trade Committee

UK-Andean countries trade agreement

Documents containing treaty information and a summary of the UK-Andean countries trade agreement.

UK pledges support to help Ukraine rebuild post conflict

The International Trade Secretary hosts high-level talks on how the international community can help rebuild Ukraine after the conflict.

GlaxoSmithKline investing in Greece

Back to News

The leading UK pharmaceutical company, Glaxo Smithkline (GSK) announced new €2.2 million investment in Greece, at the British Residence.

This investment will enable secondary packaging for 4 over-the-counter products. This will take place at FAMAR’s facilities, in the context of a long-term cooperation between the two companies. Production is expected to begin before the end of the year and will reinforce the exporting capacity of GSK Greece, as 98% of the new production will be exported to 32 countries.

The Minister for Development, Costis Hatzidakis, opened the event alongside the host, the British Ambassador, John Kittmer, who said:

I am delighted that GSK, a great British company, has decided to increase its investment in Greece. This decision shows the importance of foreign direct investment to Greece’s future and the importance of Greece’s efforts to improve the business environment.

You are not logged in!

Please login or register to ask our experts a question.

Login now or register.